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Nuts ‘n’ guts: transport of food allergens across 
the intestinal epithelium
Dwan Price1,2, Leigh Ackland1, and Cenk Suphioglu2,*
1Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Faculty of Science, Engineering and Built Environment, 
Deakin University, Burwood,  VIC 3125, Australia
2NeuroAllergy Research Laboratory, School of Life and Environmental Sciences, Faculty of Science, Engineering and Built Environment, Deakin 
University, Geelong, VIC 3216, Australia
The increase in the incidence of food allergy is a growing problem for the western world. This review will focus on the findings 
from several macromolecular epithelial transport experiments and drug permeability studies to provide a recent comprehension of 
food allergen intestinal epithelial cell transport and the allergen-epithelial relationship. Specifically, this review will aim to answer 
whether allergens can permeate the intestinal barrier directly via intestinal epithelial cells, and whether this mode of transport af-
fects downstream immune reactions. By improving our understanding of the interactions which take place during exposure of food 
allergens with the intestinal epithelium, we can begin to understand whether the epithelial barrier plays a major role in the allergic 
sensitization process rather than simply restricting the entry of allergens to the underlying lamina propria.
Key words: Food allergy; Peanut; Intestinal epithelial cell; Cell tight junctions; Cell barrier integrity; Peyer’s patch
INTRODUCTION
Today, it’s not uncommon to hear of allergy to common foods 
such as egg, milk, seafood, many fruits, tree nuts and in particular 
peanuts. Peanuts in particular are the highest contributor of 
anaphylactic deaths after ingestion of a food allergen [1]. Only 
trace amounts of peanut protein can trigger an allergic response 
[2]. It is for this reason that ‘nut-free’ schools, kindergartens and 
childcare facilities is nowadays common practice. The food 
allergy epidemic continues to lead the allergy and immunology 
zeitgeist, and will remain at the forefront of allergist investigation 
until a definitive understanding of food allergy cause and 
manifestation is achieved.
Food allergy is a growing problem for the western world. 
Recently, an Australian study involving a small population of 
children; referred to a specialist allergy clinic within the Australian 
Capital Territory, revealed that the incidence of peanut sensitivity 
in children within Australia has more than doubled since 1995 [3]. 
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A 2009 study—conducted in the United Kingdom by Venter et al. 
[4], compared the prevalence of peanut allergy for three different 
cohorts of children A, B, and C whom were either born in 1989, 
1994–1996 and 2001–2002, respectively. Peak peanut sensitisation 
was observed in cohort B at 3.3%, an increase to that observed 
in 1989 (1.3%). Interestingly, cohort C observed statistically non-
significant decrease at 2.0%. Similarly, another study revealed 
that the prevalence of peanut allergy has almost doubled from 
0.24 per 1,000 patients in 2001 to 0.51 per 1,000 patients in 2005 
as observed by an increase in diagnoses by general practitioners 
[5]. Other studies have also demonstrated similar findings [6, 7]. 
This rising trend highlights the importance of global therapeutic 
intervention and research targeted at combating the rising 
prevalence of peanut allergy.
Currently, the best means of managing the condition is strict 
avoidance. Novel therapies, such as oral immunotherapy; involving 
the administration of small amounts of allergen in a strictly 
controlled clinical setting is showing potential of being an 
effective treatment [8]. Despite this, peanut allergy has an inherent 
risk of fatal anaphylaxis [1], and is often caused by trace amounts 
of peanut [2]. Thus, not only should oral immunotherapy be 
approached with caution, the therapy may only be suitable for 
individuals with a mild response after allergen stimulation. 
The growing incidence of peanut allergy throughout westernised 
populations; and the limited available therapeutic intervention, 
purports the development of additional effective treatments 
to mediate the condition. In addition, further study into the 
mechanism of peanut allergy should be of global priority, to 
prevent greater economic burden in the future. Therefore, the aim 
of this review will focus on a relatively unexplored aspect of the 
allergen sensitization process―the initial passage through the 
intestinal epithelium. The findings from several macromolecular 
epithelial  transpor t experiments and drug permeabilit y 
studies have been collated to provide a recent comprehension 
of food allergen intestinal epithelial cell (IEC) transport. IEC 
allergen transport is relatively unaddressed in the literature. 
Thus, expanding our knowledge in this field will enhance our 
understanding of the allergen sensitization process. To address 
this, our review will briefly introduce the allergenic characteristics 
of the major allergenic food peanut, and the process by which an 
individual becomes sensitized to peanuts: from allergen to allergy. 
From here, the review will explore the various pathways that 
allergens may cross the intestinal mucosa via IEC. Specifically, this 
review will aim to answer whether peanut allergens are likely to 
permeate the intestinal barrier via IEC.
Peanut allergens
Certain characteristics of peanut allergens increase their 
allergenicity. These include the following: (1) Relative abundance. 
There are 11 peanut allergens described to date, namely Ara h 1 
through to Ara h 11; (2) Thermal [9] and proteolysis [10] stability 
to heat treatment and digestion, respectively; (3) Numerous 
IgE binding sites [11-13], which are also often internalised. Thus, 
unreachable by various digestive enzymes [14]. 
Additionally, Ara h 2 is an effective inhibitor of trypsin [15]. More 
recently, Caco-2/TC7 cells stimulated with purified native Ara h 2 
demonstrated a pro-inflammatory response, with up-regulated 
nitric oxide synthase (nos2a), interleukin (il)-6, and il-33 compared to 
proportional levels of lipopolysaccharide (LPS) [16]. Similarly, the 
epithelium-associated cytokine IL-33 was observed to play a role in 
instigating an allergic response to peanut [17], demonstrating not 
only the intrinsic interactions between allergens and the intestinal 
epithelium, but their capacity to interact and play a role in the 
downstream immune response to dietary allergens through their 
association with the intestinal epithelium. 
Antigen trafficking: antigen to allergy
Normally, allergen sensitization occurs as follows: antigens are 
selectively sampled by intestinal M cells (Fig. 1, ), which are 
modified epithelial cells specially designed for the endocytosis 
of luminal antigens [18]. From here, the antigens are displayed 
to antigen presenting cells, such as macrophages, where they 
are degraded and incorporated into an antigen presenting 
protein complex termed the major histocompatability complex 
(MHC) or human leukocyte antigen (HLA). Specifically, MHC 
class II or HLA subgroup D, respectively, are specific for allergen 
presentation. From here, down stream T and B cell activation will 
occur, which will ultimately result in the production of chemical 
mediators to elicit an immune response. Interestingly, Dreskin 
et al. [19], observed that HLA class II may not play a major role 
in the development of peanut allergy when comparing sets of 
siblings, which comprised of an allergic and non-allergic individual 
with identical HLA. Interestingly, this study also observed the 
occurrence of a relatively rare allele DRB1*0803, which may prove 
to be a risk factor for the predisposition to peanut allergy. However, 
further research is necessary to investigate this correlation.  What 
this study does suggest however, is that individual MHC differences 
does not determine whether an individual will obtain peanut 
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allergy.  However, environmental influences, antigen processing 
and epitope presentation may contribute significantly to the 
downstream sensitisation cascade. Here, allergen properties may 
impact on the extent of antigen processing prior to incorporation 
into MHC II. Therefore, mechanisms which can modify the 
allergen prior to MHC II incorporation may provide a means for 
understanding the molecular etiology of some food allergies.
The allergen sensitization begins with the transport across the 
intestinal epithelium. Transport of luminal antigens is typically 
via M cells but IECs also have the capacity to transport luminal 
antigens across the epithelium (Fig. 1,  to ), but to a different 
capacity to M cells. Peanut allergens have been detected in breast 
milk [20] suggesting that intact allergens can cross the intestinal 
epithelium and enter the circulatory system without processing. 
Whether their passage is via IEC or M cells is explored below.
Crossing the great divide: intestinal mucosal allergen 
transport 
M cell transport 
Antigen sampling by M cells is selective. Typically, this is the 
only means by which luminal antigens and macromolecules 
can cross the intestinal epithelia and are subject to processing 
by the gut immune system.  Antigens which are often insoluble 
and/or aggregated are endocytosed only via M cells [21]. Here, 
antigens encounter less protective mechanisms such as mucous 
and microvilli to be transported easier. Antigens absorbed by 
M cells are transported directly to the underlying- immune cell 
rich- lamina propria, with little to no antigen alteration before 
presentation to a professional antigen presenting cell.
Intestinal epithelial cell transport
Despite this, some macromolecules have shown the ability to 
cross the intestinal epithelium without M cell passage, including 
allergens from milk [22], brazil nuts [23], and egg [24], just to name 
a few. This can occur transcellularly, where antigens are absorbed 
directly through epithelial cells or paracellularly, where antigens 
pass through the tight junctions joining IEC (Fig. 2, a). For an in 
depth explanation of all modes of epithelial transport, Tukker [25] 
has reviewed the topic in greater detail, which is beyond the scope 
of this review. 
IECs in vivo and in vitro express many elements involved 
in antigen processing. This indicates a role for IEC in antigen 
presentation, independent of M cell involvement. HLA-DR was 
shown to be expressed in fetal intestinal epithelium from 18 
weeks gestation, specifically at villi tips. This same study identified 
interferon gamma (IFN-γ) as the stimulant for HLA-DR expression 
by HT29 IEC in vitro [26]. IFN-γ has also shown to induce the 
expression of MHC class II in another IEC line Caco-2, further 
suggesting the role of IFN-γ secreting T-lymphocytes as the stimuli 
for MHC-II expression by IEC [27]. More recently, MoS13 IECs treated 
with IFN-γ were able to stimulate proliferation of CD4+ intestinal 
epithelial lymphocytes after antigen exposure; though not to 
the capacity of professional antigen presenting cells [28]. Despite 
Fig. 1. Antigen intestinal epithelial transport. Conventional antigen 
sampling of the intestinal luminal contents occurs via specialized 
epithelial cells termed M cells. Here, antigens are randomly selected from 
luminal contents . Those antigens which are insoluble and/or have 
a tendency to aggregate are restricted to crossing the mucosal barrier 
by this mechanism. Digested peanut allergens aggregate in neutral 
conditions, and are therefore likely restricted to mucosal passage via M 
cells only. Therefore, individuals who have a normal digestion capacity 
(years 2+) are more likely to have peanut allergens absorbed by this 
mechanism. Despite this, soluble and non-aggregated antigens have the 
capacity to cross the mucosal barrier through intestinal epithelial cells 
(IECs). This means that antigens in non-aggregated or more soluble states, 
such as undigested peanut allergens (peanut ingested by an individual 
with decreased digestion capacity or a ‘leaky gut’; such as an infant) have 
an additional pathway for those allergens to cross the mucosal barrier 
and allow exposure to underlying immune cells. IEC passage may either 
be by parracellular transport  or transcellular transport . Additionally, 
antigens may be processed and expressed on major histocompatability 
complex (MHC) II by IEC .
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this, levels of IFN-γ secreted by the CD4+ intestinal epithelial 
lymphocytes was significantly higher when in the presence of 
IEC compared to professional antigen presenting cells, where the 
increase in IFN-γ secretion was unique to intestinal epithelial CD4+ 
lymphocytes and not those found elsewhere in the body [28]. In 
addition to MHC-II expression and IFN-Υ secretion by IEC, many 
additional antigen processing components have been identified 
in the IEC line HT29, which were comparable to those expressed 
in human small intestinal biopsy tissue [29]. Other studies have 
demonstrated similar results regarding IEC capability to secrete 
exosomes with antigen presenting components, with the potential 
capacity for antigen presentation to downstream immune cells 
[29-31], given that IEC have the capacity to absorb and process 
antigens. It is of particular interest to summarize any food allergens 
that have been observed to cross IEC, either paracellularly or 
transcellularly, independent of M cells. 
Intestinal epithelial cell paracellular transport
Paracellular transport is directly related to the integrity of the 
intestinal epithelium and is controlled primarily by the tight 
junction (Fig. 2, a). Although transport via this way may not involve 
antigen processing by the IEC as such, IEC transport may influence 
the quantity of allergen passing through to the lamina propria. 
The tight junctions are located on the apicolateral cell membrane, 
and attach laterally to neighbouring cells. Thus, tight junctions are 
directly involved in the permeability and polarity of the intestinal 
epithelium, as their main function is to exclude luminal contents. 
Thus, any antigen that can cross here will be directly exposed 
to underlying immune cells in the lamina propria, effectively 
triggering the allergenic cascade, in an uncontrolled manner. 
To explore the role that tight junctions play in disorders that alter 
intestinal permeability, including food allergy, we must first gain a 
brief understanding about the tight junction structure (Fig. 3). 
The tight junction is comprised of two main units. Transmembrane 
protein complexes which span the paracellular space, and 
intracellular protein complexes which bind the structural elements 
of the cytoskeleton; such as actin. The transmembrane complexes 
are comprised of occludin [32], junctional adhesion molecule (JAM) 
[33] and members of the claudin family, which differ with tissue 
type [34]. Those proteins which are involved in the joining of the 
transmembrane proteins to the cytoskeleton, include zonula-
occludins (ZO)-1 [35, 36], ZO-2 [36, 37], and ZO-3 [38], just to name 
a few. There are also numerous other proteins, which have been 
observed to localise to the tight junction, and are involved in 
cytoskeletal adhesion, but will not be explored in this review. They 
are however, adequately descried in several recent reviews by 
Niessen [39] and Gonzalez-Mariscal et al. [40]. 
The malfunctioning of tight junctions is associated with many 
diseases, including cancer, jaundice, edema, and colitis [41-44]. The 
role that the tight junction plays in these conditions is described in 
a review by Sawada et al. [45]. The function that the tight junction 
plays in the physiology of food allergy is less defined. Additionally, 
allergen paracellular IEC transport via tight junctions is scarcely 
Fig. 2. The transport mechanisms of materials through epithelium. 
Paracellular transport (a), transcellular transport by diffusion (b), facilitated 
diffusion (c), transcytosis (d), endocytosis (e), active transport (f ), and 
finally, eff lux (g). Paracellular transport, is related to tight junction 
integrity, while transport mechanisms (b) to (f) are all loosely described as 
transcellular transport mechanisms. Efflux (g) will not be discussed in this 
review. 
Fig. 3. Tight junction structure.  Transmembrane complexes involving 
occludin, claudin, and junctional adhesion molecule (JAM) tether the 
cytoskeleton through intracellular protein complexes. ZO-1, zonula-
occludins 1.     
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addressed in the literature.
Experimental evidence for allergen transport across the intestinal 
mucosa is generally limited. However, a 2004 study by Chambers 
et al. [46], investigated the epithelial transport of peanut protein 
in BALB/c mice. This group observed both soluble protein and 
protein bodies in the cytoplasm of M cells within intestinal Peyer’s 
patches. Interestingly, peanut bodies were also observed in the 
paracellular space between epithelial cells surrounding Peyer’s 
patches but not in epithelial cells that were not adjacent to Peyer’s 
patches [46]. This indicates the potential for peanut allergen 
paracellular passage, but also illustrates that peanut allergen IEC 
passage may be restricted to M cells only. Thus, more research is 
required to properly understand the transport of peanut allergens 
across the human intestinal mucosa. 
The certain qualities of allergens that make them particularly 
more allergenic, for example heat resistance and digestion 
resistance, is reiterated with other potentially destructive qualities 
such as specific protease activity aimed at epithelial destruction. 
For example, although not a food allergen per se, the major house 
dust mite allergen Der p 1 effectively compromises the integrity 
of airway epithelium via tight junction destruction, resulting in 
the cleavage of occludin and increased paracellular permeability 
through a proteolytic mechanism [47]. This not only illustrates the 
invasive potential of successful allergens, such as those from dust 
mites, but also highlights the importance of the tight junctions in 
allergic disease.
Intestinal epithelial cell transcellular transport
Trancellular transport, or the movement of materials through 
epithelial cells, occurs either by simple diffusion (a), diffusion 
mediated by carrier proteins (b) or vesicular transport either by 
trancytosis (c), endocytosis (d) or active transport (e). For simple 
diffusion based transcellular transport, a compound is limited by 
its lipophilicity, solubility, concentration and absorption area. This 
could help to explain when the epithelial transport of the egg 
allergen ovomucoid was studied in Caco-2 cells, they were pre-
treated with varying concentrations of food grade surfactants; the 
added surfactants effectively increased the permeability of the 
egg allergen when surfactant levels were < 50 µg/well or 25  µg/
mL [24]. 
For more hydrophilic and poorly absorbed materials, carrier 
mediated transport is typically the main route. Carrier mediated 
transport can occur via dif fusion, where, with the help of 
membrane bound carrier proteins, luminal particulates can be 
transported down its concentration gradient. Alternatively, this 
process can utilise a source of energy such as the conversion of 
adenosine triphosphate (ATP) to adenosine diphosphate to drive 
a protein pump, such as the sodium/potassium ATPase pump. 
This process can operate against a concentration gradient and is 
typically used for materials in very low external concentrations.  
Endocytosis and transcytosis are two additional transport 
methods where external materials are engulfed by the cell 
membrane and enclosed and transported within vesicles 
within the cell. Generally, when analysing the transport method 
for various materials using cellular based models (i.e., Caco-
2 monolayers), the transepithelial resistance (TEER) is used 
to address the integrity of the monolayer, where a change in 
TEER denotes alteration to tight junctions and thus relates to 
paracellular transport. Studies that exclude paracellular modes 
and thus accept transcellular modes, usually do so based on TEER 
and other markers for paracellular permeability. For example, 
purified wheat allergens ω5-gliadin and lipid transfer protein (LTP) 
were able to cross Caco-2 monolayers and detected by enzyme-
linked immunosorbent assay (ELISA). Here, Caco-2 monolayer 
integrity was not compromised as no increase in permeability was 
observed via TEER or dextran flux. Also interestingly, digestion 
of the wheat allergens appeared to enhance their transcellular 
transport capacity [48], indicating the preferable uptake of 
digested allergens compared to whole allergens. It is likely that 
digestion may have rendered the allergen more soluble, allowing 
easier IEC absorption. Another study by Moreno et al. [23], reports 
the transcellular transport of purified 2s albumins Ber e 1 and 
Ses i 1 within Caco-2 monolayers, both of which are major brazil 
and white sesame seed allergens, respectively. Here, both Ber e 
1 and Ses i 1 did not appear to affect permeability as observed 
with no change to allergen absorption rate, TEER or phenol red 
absorption. Considering this, we can assume that the peanut 
2S albumins, Ara h 2, Ara h 6, and Ara h 7 [49] may have the 
potential to cross the epithelial barrier by similar means, due to 
conserved structural conformations. Recently, purified Ara h 2 has 
been observed to be endocytosed by HT-29 cells and targeted 
for lysosomal degradation after endosomal fusion, where the 
ubiquitin E3 ligase A20 is involved in its lysosomal degradation 
[50]. Also, the transport of the egg allergen ovalbumin is subject to 
its phosphorylation state, where it was found that apical to basal 
transport of dephosphorylated ovalbumin is reduced compared 
to its phosphorylated form, a result that is averted with the 
protease inhibitor leupeptin, suggesting lysosomal degradation 
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during IEC transport [51]. Both of the above studies highlight the 
added importance of IEC digestion survival as an added element 
of allergen potency. Additionally of interest, the major soybean 
allergen, Gly m 1, has been shown to be endocytosed by IPEC-J2 
cells in vitro [52].
Allergen characteristics promoting IEC transport
As discussed earlier, protein solubility and aggregation can 
dictate the method of mucosal transport an allergen may take 
to cross the intestinal mucosa. While insoluble aggregated 
antigens are restricted to M cell transport, the more soluble non-
aggregated antigens can potentially cross via normal IEC. This 
passage of soluble antigens through IEC is thought to be critical 
in the induction of allergic disease, at least for milk allergens [22]. 
Given this, it is important to note that allergens from roasted 
peanuts are less soluble than raw peanuts. However, insolubility 
can be ameliorated with amylase treatment or by a pH of 2 [9]. 
Additionally, Ara h 3, also upon heat treatment, formed insoluble 
aggregates, which were completely degraded during pepsin 
digestion, and thus incapable of significantly binding IgE [53]. 
Therefore, under normal digestive conditions, Ara h 3 does not 
appear to be a major contributor to sensitization to peanuts. 
However, in individuals with decreased digestive capacity, such 
as infants, Ara h 3 may reach the intestinal lumen, in its insoluble 
form aggregates, and may expose the immune system via M cell 
infiltration. 
The type of heat treatment was also observed to affect the 
aggregation of Ara h 1. Where, boiling and roasting affected the 
major peanut allergens’ aggregate structure, with the roasted 
aggregate of Ara h 1 retaining higher IgE reactivity compared 
to boiled Ara h 1 [54]. Similarly, Ara h 2 was also observed to 
aggregate after heat treatment [16]. Stronger immune eliciting 
capacity was confirmed in brown Norway rats for roasted peanuts 
compared to boiled peanuts. Interestingly, whether the peanuts 
were boiled or roasted did not effect the sensitization capacity 
of peanuts [55].  Also, recombinant Ara h 2 was more IgE reactive 
when heated compared to untreated, however negligible 
differences were observed between natural, untreated and heated 
Ara h 2 [16]. 
Given all this, it is likely that peanut allergen aggregates, made 
insoluble after heat treatment, do not have the capacity to cross 
the intestinal mucosa via IEC but only via M cells. Future research 
into this conjecture would be useful in the further understanding 
of the sensitization mechanism of peanut allergy.
CONCLUSION
Allergen transport across the intestinal mucosa is largely 
unreported in the literature. It is highly likely that allergen 
transport, gut permeability and tolerance induction are intrinsically 
linked in the development of food allergy. 
Firstly, we have observed that allergen can cross the intestinal 
mucosa via IEC. Certain allergens such as the house dust mite 
Der p 1 has protease activity that can disrupt tight junctions and 
increase paracellular permeability. In vivo studies have shown that 
peanut protein bodies have been observed in the paracellular 
space of epithelial cells adjacent to M cells, but not in those 
further away from the Peyer’s patches. On the other hand, in vitro 
studies have shown that soybean Gly m 1, can be endocytosed by 
IPEC-J2 cells [52] and purified Ara h 2 can be endocytosed by HT-
29 cells and additionally targeted for lysosomal degradation after 
endosomal fusion [50]. In vitro studies have additionally shown the 
IEC transcellular translocation of the wheat allergens ω5 gliadin 
and lipid transfer protein [48], and the brazil nut and white sesame 
allergens Ber e 1 and Ses i 1 [23], respectively, all of which highlight 
the IEC translocating capacity of food allergens.
The absorption of food allergens from the gut lumen, without 
M cell passage, is not thoroughly explored. Additional means of 
absorption may well explain why some allergens are more potent 
allergens than others, like that of house dust mite, and why some 
food allergies are persistent through to adulthood. More data is 
required on the permeability and absorption of food allergens for 
a verdict to be made regarding whether mucosal permeability 
may increase an allergen’s potency. Also, if more understanding 
is gained on additional modes of transport for specific food 
allergens, like Ber e 1 and Ses i 1 studies mentioned above, then 
this provides additional means for therapeutic targeting regarding 
specific allergies to foods. Currently, there is lack of data on the 
transport capabilities of many food allergens and their route of 
exposure to the mucosal immune system. This highlights the 
importance of further investigation into the absorption of food 
allergens across the intestinal mucosa. 
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